Lv3
230 积分 2025-06-26 加入
When topicals fall short, oral Janus kinase inhibitors offer a needed solution in chronic hand eczema
13天前
已完结
Risk factors that limit use of oral JAK inhibitors in chronic hand eczema: Findings from the Danish Skin Cohort
13天前
已完结
Structural Basis for Differential Jak2 and Jak3 Kinase Selectivity of Ruxolitinib and Delgocitinib
17天前
已关闭
The efficacy and safety of JAK inhibitors in patients with adult-onset still's disease: A meta-analysis and systematic review
18天前
已完结
Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts
18天前
已完结
Adult-Onset Still’s Disease—A Complex Disease, a Challenging Treatment
18天前
已完结
Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
18天前
已关闭
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease
18天前
已完结
Quick Treatment of Very Severe Refractory Hand and Foot Eczema with Dupilumab: A Case Report and Literature Review
25天前
已完结
Treatment of chronic hand eczema with dupilumab—A retrospective follow‐up study
26天前
已关闭
皖公网安备34019202002308
